Title: A novel immune checkpoint score system for prognostic evaluation in pancreatic
adenocarcinoma
Version: 2 Date: 08 Aug 2022
Reviewer's report:
Abstract has not been divided into subheadings.
Minor grammatical errors need to be addressed.
Table 1 - correct spelling of unknown, use alive instead of survival
Table 1- Most patients's M stage is listed as  M0 and unknown - so is the model appropriate
for metastatic patients as well.
Title: A novel immune checkpoint score system for prognostic evaluation in pancreatic
adenocarcinoma
Version: 2 Date: 08 Aug 2022
Reviewer's report:
Abstract has not been divided into subheadings.
Minor grammatical errors need to be addressed.
Table 1 - correct spelling of unknown, use alive instead of survival
Table 1- Most patients's M stage is listed as  M0 and unknown - so is the model appropriate
for metastatic patients as well.
Please review this paper.
user
Title: A novel immune checkpoint score system for prognostic evaluation in pancreatic
adenocarcinoma
Version: 2 Date: 08 Aug 2022
Reviewer's report:
Abstract has not been divided into subheadings.
Minor grammatical errors need to be addressed.
Table 1 - correct spelling of unknown, use alive instead of survival
Table 1- Most patients's M stage is listed as  M0 and unknown - so is the model appropriate
for metastatic patients as well.
assistant